References
- An K, Sun Y, Xu L, Yuan H. 2011. Preparation and in vitro evaluation of simvastatin Ethosome [J]. Artif Cells Blood Substi Biotechnol. 39:347–350.
- Barry BW. 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 14:101–114.
- Chen JG, Liu YF, Gao TW. 2010. Preparation and anti-inflammatory activity of triptolide ethosomes in an erythema model. J Liposome Res. 20:297–303.
- de la Presa P, Rueda T, del Puerto Morales M, Javier Chichón F, Arranz R, Valpuesta JM, Hernando A. 2009. Gold nanoparticles generated in ethosome bilayers, as revealed by cryo-electron-tomography. J Phys Chem B. 113:3051–3057.
- Dubey V, Mishra D, Nahar M, Jain V, Jain NK. 2010. Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes. Nanomedicine. 6:590–595.
- Krysiak R, Okopien B. 2010. Different effects of simvastatin on ex vivo monocyte cytokine release in patients with hypercholesterolemia and impaired glucose tolerance. J Physiol Pharmacol. 61:725–732.
- Lagrost L, Athias A, Lemort N, Richard JL, Desrumaux C, Châtenet-Duchêne L, et al. 1999. Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin. Atherosclerosis. 143:415–425.
- Madsen JT, Vogel S, Johansen JD, Sørensen JA, Andersen KE, Nielsen JB. 2011. Percutaneous penetration characteristics and release kinetics of contact allergens encapsulated in ethosomes. Cutan Ocul Toxicol. 30:38–44.